

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 5.51555316 |
| 2 | cardiac myofibril assembly (GO:0055003) | 5.29987926 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.00081389 |
| 4 | carnitine shuttle (GO:0006853) | 4.86687262 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.81337538 |
| 6 | myofibril assembly (GO:0030239) | 4.54295321 |
| 7 | cardiac muscle contraction (GO:0060048) | 4.42388719 |
| 8 | fatty acid transmembrane transport (GO:1902001) | 4.37301157 |
| 9 | tricarboxylic acid cycle (GO:0006099) | 4.33269136 |
| 10 | plasma membrane repair (GO:0001778) | 4.30711806 |
| 11 | lysine metabolic process (GO:0006553) | 4.24853791 |
| 12 | lysine catabolic process (GO:0006554) | 4.24853791 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.22912288 |
| 14 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.10006515 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.09787234 |
| 16 | semaphorin-plexin signaling pathway (GO:0071526) | 4.08458863 |
| 17 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.06089483 |
| 18 | 2-oxoglutarate metabolic process (GO:0006103) | 3.92632075 |
| 19 | cell communication involved in cardiac conduction (GO:0086065) | 3.91281386 |
| 20 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.89828672 |
| 21 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.89564201 |
| 22 | carnitine transmembrane transport (GO:1902603) | 3.86330343 |
| 23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.84731139 |
| 24 | cell communication by electrical coupling (GO:0010644) | 3.77287136 |
| 25 | carnitine transport (GO:0015879) | 3.75673588 |
| 26 | amino-acid betaine transport (GO:0015838) | 3.75673588 |
| 27 | cardiac muscle cell development (GO:0055013) | 3.75659182 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.75287455 |
| 29 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.72992916 |
| 30 | actomyosin structure organization (GO:0031032) | 3.70668865 |
| 31 | aspartate family amino acid catabolic process (GO:0009068) | 3.70306937 |
| 32 | muscle filament sliding (GO:0030049) | 3.69765971 |
| 33 | actin-myosin filament sliding (GO:0033275) | 3.69765971 |
| 34 | mannose metabolic process (GO:0006013) | 3.68322650 |
| 35 | adult heart development (GO:0007512) | 3.62476298 |
| 36 | regulation of actin filament-based movement (GO:1903115) | 3.61895201 |
| 37 | regulation of extracellular matrix disassembly (GO:0010715) | 3.61094106 |
| 38 | cardiac cell development (GO:0055006) | 3.58669528 |
| 39 | regulation of female receptivity (GO:0045924) | 3.53769676 |
| 40 | heart trabecula formation (GO:0060347) | 3.52099121 |
| 41 | lung epithelium development (GO:0060428) | 3.46877638 |
| 42 | regulation of fatty acid oxidation (GO:0046320) | 3.44581321 |
| 43 | regulation of ARF GTPase activity (GO:0032312) | 3.44164489 |
| 44 | cell-cell junction maintenance (GO:0045217) | 3.39727013 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 3.39696875 |
| 46 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.39407958 |
| 47 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.37053068 |
| 48 | striated muscle contraction (GO:0006941) | 3.36745945 |
| 49 | proline metabolic process (GO:0006560) | 3.36263351 |
| 50 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.31257514 |
| 51 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.26100211 |
| 52 | cardiac muscle hypertrophy (GO:0003300) | 3.25836415 |
| 53 | tricarboxylic acid metabolic process (GO:0072350) | 3.24653029 |
| 54 | regulation of membrane repolarization (GO:0060306) | 3.24292233 |
| 55 | fatty acid beta-oxidation (GO:0006635) | 3.23578614 |
| 56 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.21634855 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.20344892 |
| 58 | alpha-linolenic acid metabolic process (GO:0036109) | 3.18412108 |
| 59 | negative regulation of cell size (GO:0045792) | 3.17492418 |
| 60 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.14370894 |
| 61 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.13925290 |
| 62 | protein retention in ER lumen (GO:0006621) | 3.13133095 |
| 63 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.10056476 |
| 64 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.09594982 |
| 65 | striated muscle hypertrophy (GO:0014897) | 3.09392045 |
| 66 | adherens junction assembly (GO:0034333) | 3.09276773 |
| 67 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.08865137 |
| 68 | female mating behavior (GO:0060180) | 3.08632412 |
| 69 | regulation of the force of heart contraction (GO:0002026) | 3.05879903 |
| 70 | quaternary ammonium group transport (GO:0015697) | 3.04469422 |
| 71 | positive regulation of synapse maturation (GO:0090129) | 3.04078955 |
| 72 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.03187164 |
| 73 | fatty acid homeostasis (GO:0055089) | 3.02932332 |
| 74 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.99498606 |
| 75 | actin-mediated cell contraction (GO:0070252) | 2.97812534 |
| 76 | stress granule assembly (GO:0034063) | 2.96509582 |
| 77 | NADH metabolic process (GO:0006734) | 2.94420434 |
| 78 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93704368 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.92924631 |
| 80 | focal adhesion assembly (GO:0048041) | 2.92848745 |
| 81 | cell-substrate adherens junction assembly (GO:0007045) | 2.92848745 |
| 82 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.92188045 |
| 83 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90560840 |
| 84 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.88098994 |
| 85 | COPI coating of Golgi vesicle (GO:0048205) | 2.87172703 |
| 86 | Golgi transport vesicle coating (GO:0048200) | 2.87172703 |
| 87 | cardiac muscle cell action potential (GO:0086001) | 2.86928722 |
| 88 | regulation of extracellular matrix organization (GO:1903053) | 2.86063647 |
| 89 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.85888203 |
| 90 | cardiac conduction (GO:0061337) | 2.84745637 |
| 91 | regulation of striated muscle contraction (GO:0006942) | 2.84724740 |
| 92 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.83842788 |
| 93 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83757919 |
| 94 | short-chain fatty acid metabolic process (GO:0046459) | 2.83020342 |
| 95 | creatine metabolic process (GO:0006600) | 2.79594191 |
| 96 | fatty acid oxidation (GO:0019395) | 2.79250854 |
| 97 | regulation of cholesterol homeostasis (GO:2000188) | 2.78583435 |
| 98 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.78506484 |
| 99 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.75868957 |
| 100 | muscle tissue morphogenesis (GO:0060415) | 2.75845050 |
| 101 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.75512230 |
| 102 | proline biosynthetic process (GO:0006561) | 2.74393689 |
| 103 | potassium ion import (GO:0010107) | 2.73383719 |
| 104 | lipid oxidation (GO:0034440) | 2.73263091 |
| 105 | glyoxylate metabolic process (GO:0046487) | 2.72237077 |
| 106 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.71395864 |
| 107 | regulation of cholesterol metabolic process (GO:0090181) | 2.70965659 |
| 108 | fatty acid catabolic process (GO:0009062) | 2.70317646 |
| 109 | cell volume homeostasis (GO:0006884) | 2.70258810 |
| 110 | biotin metabolic process (GO:0006768) | 2.69821756 |
| 111 | basement membrane organization (GO:0071711) | 2.69800434 |
| 112 | sodium ion export (GO:0071436) | 2.69244638 |
| 113 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.68741762 |
| 114 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.67806699 |
| 115 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.67776436 |
| 116 | glycogen catabolic process (GO:0005980) | 2.67540823 |
| 117 | cell migration in hindbrain (GO:0021535) | 2.67433746 |
| 118 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.67066601 |
| 119 | cellular ketone body metabolic process (GO:0046950) | 2.66498928 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 2.66138774 |
| 121 | apoptotic process involved in morphogenesis (GO:0060561) | 2.63425045 |
| 122 | regulation of heart rate (GO:0002027) | 2.63274985 |
| 123 | actin filament-based movement (GO:0030048) | 2.62510021 |
| 124 | cerebellar granule cell differentiation (GO:0021707) | 2.62341589 |
| 125 | oxaloacetate metabolic process (GO:0006107) | 2.62301652 |
| 126 | negative regulation of potassium ion transport (GO:0043267) | 2.62207073 |
| 127 | muscle hypertrophy (GO:0014896) | 2.61590687 |
| 128 | glucan catabolic process (GO:0009251) | 2.61359864 |
| 129 | histone H4 deacetylation (GO:0070933) | 2.60318216 |
| 130 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.60095509 |
| 131 | relaxation of cardiac muscle (GO:0055119) | 2.59954844 |
| 132 | negative regulation of cholesterol transport (GO:0032375) | 2.59954143 |
| 133 | negative regulation of sterol transport (GO:0032372) | 2.59954143 |
| 134 | layer formation in cerebral cortex (GO:0021819) | 2.59480203 |
| 135 | cardiac muscle adaptation (GO:0014887) | 2.59424193 |
| 136 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.59424193 |
| 137 | muscle hypertrophy in response to stress (GO:0003299) | 2.59424193 |
| 138 | cell junction maintenance (GO:0034331) | 2.58731131 |
| 139 | cardiac muscle cell proliferation (GO:0060038) | 2.58545249 |
| 140 | negative regulation of heart growth (GO:0061117) | 2.57545864 |
| 141 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.57545864 |
| 142 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.57440109 |
| 143 | activation of Rac GTPase activity (GO:0032863) | 2.56820864 |
| 144 | regulation of early endosome to late endosome transport (GO:2000641) | 2.51177233 |
| 145 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.49856685 |
| 146 | endothelial cell chemotaxis (GO:0035767) | 2.47596778 |
| 147 | regulation of apoptotic cell clearance (GO:2000425) | 2.47375827 |
| 148 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.44729541 |
| 149 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.43648542 |
| 150 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.41623211 |
| 151 | maternal placenta development (GO:0001893) | 2.40899046 |
| 152 | glucose 6-phosphate metabolic process (GO:0051156) | 2.40631253 |
| 153 | regulation of response to osmotic stress (GO:0047484) | 2.39643548 |
| 154 | atrioventricular valve morphogenesis (GO:0003181) | 2.39201925 |
| 155 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.38255005 |
| 156 | protein-lipid complex assembly (GO:0065005) | 2.36173257 |
| 157 | activation of JUN kinase activity (GO:0007257) | 2.35539078 |
| 158 | negative regulation of fatty acid transport (GO:2000192) | 2.34717775 |
| 159 | regulation of synapse maturation (GO:0090128) | 2.34454956 |
| 160 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.33152604 |
| 161 | epithelial cell-cell adhesion (GO:0090136) | 2.33098508 |
| 162 | histone H3-K9 demethylation (GO:0033169) | 2.32726908 |
| 163 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.32674106 |
| 164 | negative regulation of myotube differentiation (GO:0010832) | 2.31645627 |
| 165 | signal complex assembly (GO:0007172) | 2.29761483 |
| 166 | modulation by virus of host morphology or physiology (GO:0019048) | 2.27835139 |
| 167 | mating behavior (GO:0007617) | 2.26891862 |
| 168 | synaptic vesicle exocytosis (GO:0016079) | 2.26158443 |
| 169 | plasma lipoprotein particle assembly (GO:0034377) | 2.25117112 |
| 170 | amino acid import (GO:0043090) | 2.23273163 |
| 171 | 4-hydroxyproline metabolic process (GO:0019471) | 2.22715861 |
| 172 | positive regulation of extracellular matrix organization (GO:1903055) | 2.21417462 |
| 173 | activation of protein kinase A activity (GO:0034199) | 2.21106537 |
| 174 | cell-substrate junction assembly (GO:0007044) | 2.20563550 |
| 175 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.19019762 |
| 176 | neuronal ion channel clustering (GO:0045161) | 2.18687026 |
| 177 | positive regulation of histone deacetylation (GO:0031065) | 2.18630995 |
| 178 | stress fiber assembly (GO:0043149) | 2.18431587 |
| 179 | vitamin transmembrane transport (GO:0035461) | 2.17117063 |
| 180 | protein targeting to plasma membrane (GO:0072661) | 2.16727876 |
| 181 | response to laminar fluid shear stress (GO:0034616) | 2.16025060 |
| 182 | dopamine receptor signaling pathway (GO:0007212) | 2.15223179 |
| 183 | osteoblast development (GO:0002076) | 2.15052881 |
| 184 | barbed-end actin filament capping (GO:0051016) | 2.14663405 |
| 185 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.12642058 |
| 186 | positive regulation of protein dephosphorylation (GO:0035307) | 2.12127729 |
| 187 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.11692951 |
| 188 | activation of MAPKKK activity (GO:0000185) | 2.11495926 |
| 189 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.11243954 |
| 190 | mitochondrion transport along microtubule (GO:0047497) | 2.11243954 |
| 191 | diacylglycerol metabolic process (GO:0046339) | 2.10254762 |
| 192 | epithelial structure maintenance (GO:0010669) | 2.10053478 |
| 193 | embryonic process involved in female pregnancy (GO:0060136) | 2.09325905 |
| 194 | neuromuscular process controlling balance (GO:0050885) | 2.08188985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.08006792 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.91752300 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.86053026 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.77120282 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.74997049 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47972391 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.43321792 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.37562510 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.28404748 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.24784090 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.21355277 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21206114 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.17889316 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.15234529 |
| 15 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.15234529 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.11677697 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.05709362 |
| 18 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.99309020 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.98009862 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.88698632 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.88093623 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.87392168 |
| 23 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.86994831 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.86567203 |
| 25 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.85736542 |
| 26 | KDM2B_26808549_Chip-Seq_K562_Human | 1.85720914 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.83992459 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83155428 |
| 29 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.81258583 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77431725 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74169156 |
| 32 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.69047455 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67511742 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66799752 |
| 35 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.65555183 |
| 36 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.62863340 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59056659 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56025826 |
| 39 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.55161639 |
| 40 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.53120497 |
| 41 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51162341 |
| 42 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50180362 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49575819 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49439206 |
| 45 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.47842407 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.44698333 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.44180179 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42298939 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42212149 |
| 50 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40610180 |
| 51 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.39721890 |
| 52 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.38100775 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38077319 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37233414 |
| 55 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37103694 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36925768 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.36593146 |
| 58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32807814 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32692411 |
| 60 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.29561188 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.29210649 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28578500 |
| 63 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27031457 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25879102 |
| 65 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.25219723 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23263670 |
| 67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22131411 |
| 68 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.21658015 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18691448 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18220661 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18130295 |
| 72 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17411497 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17109927 |
| 74 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.16340382 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15977748 |
| 76 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.15841367 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14866365 |
| 78 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12611526 |
| 79 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.11318535 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10027561 |
| 81 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.09701476 |
| 82 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.09551188 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08738478 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08111234 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07501261 |
| 86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.06533497 |
| 87 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.06533497 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06020524 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.06000436 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 1.05908883 |
| 91 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05650885 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05484638 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05032933 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.04815553 |
| 95 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.04500799 |
| 96 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.04461207 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04340948 |
| 98 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.03994287 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03631614 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.01448752 |
| 101 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01361007 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.01163190 |
| 103 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01081496 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.00771047 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99981988 |
| 106 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99695087 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98461646 |
| 108 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.98394068 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98033307 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96819044 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96381287 |
| 112 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96374393 |
| 113 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.96335185 |
| 114 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95723096 |
| 115 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.95574674 |
| 116 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95052340 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94557476 |
| 118 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94448176 |
| 119 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94314441 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.94081016 |
| 121 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.91947518 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91878079 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91028384 |
| 124 | SPI1_23127762_ChIP-Seq_K562_Human | 0.89944174 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89787646 |
| 126 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89460409 |
| 127 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88982318 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.87557794 |
| 129 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.87448532 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87390574 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 0.87047540 |
| 132 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86716013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.66150693 |
| 2 | MP0003646_muscle_fatigue | 4.23701559 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.22202829 |
| 4 | MP0000751_myopathy | 4.19702518 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.69497966 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.60202947 |
| 7 | MP0004215_abnormal_myocardial_fiber | 3.53963372 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.33876144 |
| 9 | MP0005409_darkened_coat_color | 3.10537666 |
| 10 | MP0005330_cardiomyopathy | 3.02582038 |
| 11 | MP0004130_abnormal_muscle_cell | 2.83596372 |
| 12 | MP0000749_muscle_degeneration | 2.79270183 |
| 13 | MP0004087_abnormal_muscle_fiber | 2.63367687 |
| 14 | MP0005360_urolithiasis | 2.55012418 |
| 15 | MP0008260_abnormal_autophagy | 2.52714253 |
| 16 | MP0003137_abnormal_impulse_conducting | 2.40900484 |
| 17 | MP0005451_abnormal_body_composition | 2.37716773 |
| 18 | MP0000566_synostosis | 2.34798013 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 2.34437948 |
| 20 | MP0010630_abnormal_cardiac_muscle | 2.33744046 |
| 21 | MP0002249_abnormal_larynx_morphology | 2.32663673 |
| 22 | MP0002972_abnormal_cardiac_muscle | 2.27007415 |
| 23 | MP0008961_abnormal_basal_metabolism | 2.12060136 |
| 24 | MP0005620_abnormal_muscle_contractility | 2.11417145 |
| 25 | MP0002269_muscular_atrophy | 2.10924446 |
| 26 | MP0003283_abnormal_digestive_organ | 2.05496132 |
| 27 | MP0001544_abnormal_cardiovascular_syste | 2.03944595 |
| 28 | MP0005385_cardiovascular_system_phenoty | 2.03944595 |
| 29 | MP0005085_abnormal_gallbladder_physiolo | 2.03149331 |
| 30 | MP0008775_abnormal_heart_ventricle | 2.03059193 |
| 31 | MP0006138_congestive_heart_failure | 2.02962987 |
| 32 | MP0000678_abnormal_parathyroid_gland | 2.01107824 |
| 33 | MP0009278_abnormal_bone_marrow | 1.96058450 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.94876540 |
| 35 | MP0002234_abnormal_pharynx_morphology | 1.91041793 |
| 36 | MP0005670_abnormal_white_adipose | 1.86673338 |
| 37 | MP0003183_abnormal_peptide_metabolism | 1.86661002 |
| 38 | MP0005365_abnormal_bile_salt | 1.86332707 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.81370865 |
| 40 | MP0005666_abnormal_adipose_tissue | 1.81368457 |
| 41 | MP0004085_abnormal_heartbeat | 1.78884621 |
| 42 | MP0004145_abnormal_muscle_electrophysio | 1.74721452 |
| 43 | MP0004233_abnormal_muscle_weight | 1.74598714 |
| 44 | MP0003123_paternal_imprinting | 1.69069735 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.68603607 |
| 46 | MP0000750_abnormal_muscle_regeneration | 1.68340244 |
| 47 | MP0000747_muscle_weakness | 1.67525939 |
| 48 | MP0002822_catalepsy | 1.63904305 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.58947910 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 1.58634298 |
| 51 | MP0010329_abnormal_lipoprotein_level | 1.57503952 |
| 52 | MP0003690_abnormal_glial_cell | 1.56989118 |
| 53 | MP0004185_abnormal_adipocyte_glucose | 1.49727307 |
| 54 | MP0003252_abnormal_bile_duct | 1.46570468 |
| 55 | MP0004270_analgesia | 1.42908279 |
| 56 | MP0004484_altered_response_of | 1.41561073 |
| 57 | MP0005369_muscle_phenotype | 1.41207514 |
| 58 | MP0003122_maternal_imprinting | 1.40849941 |
| 59 | MP0003879_abnormal_hair_cell | 1.37991863 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.37707408 |
| 61 | MP0003634_abnormal_glial_cell | 1.36766817 |
| 62 | MP0005083_abnormal_biliary_tract | 1.36754645 |
| 63 | MP0005423_abnormal_somatic_nervous | 1.34027416 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.33612407 |
| 65 | MP0004043_abnormal_pH_regulation | 1.26025333 |
| 66 | MP0009840_abnormal_foam_cell | 1.25814767 |
| 67 | MP0002127_abnormal_cardiovascular_syste | 1.25477555 |
| 68 | MP0003828_pulmonary_edema | 1.24029911 |
| 69 | MP0003303_peritoneal_inflammation | 1.21079938 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 1.18805875 |
| 71 | MP0001666_abnormal_nutrient_absorption | 1.15737531 |
| 72 | MP0008569_lethality_at_weaning | 1.14489415 |
| 73 | MP0003635_abnormal_synaptic_transmissio | 1.13909602 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 1.11617810 |
| 75 | MP0004381_abnormal_hair_follicle | 1.10391802 |
| 76 | MP0003091_abnormal_cell_migration | 1.09395630 |
| 77 | MP0001348_abnormal_lacrimal_gland | 1.08901543 |
| 78 | MP0000266_abnormal_heart_morphology | 1.08361468 |
| 79 | MP0002118_abnormal_lipid_homeostasis | 1.05451377 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04656049 |
| 81 | MP0000920_abnormal_myelination | 1.04318751 |
| 82 | MP0001958_emphysema | 1.02861086 |
| 83 | MP0010368_abnormal_lymphatic_system | 1.01281350 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 1.00498684 |
| 85 | MP0003878_abnormal_ear_physiology | 1.00498684 |
| 86 | MP0003436_decreased_susceptibility_to | 1.00404302 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.99951223 |
| 88 | MP0004510_myositis | 0.99774579 |
| 89 | MP0001502_abnormal_circadian_rhythm | 0.98621289 |
| 90 | MP0000681_abnormal_thyroid_gland | 0.94664704 |
| 91 | MP0004858_abnormal_nervous_system | 0.93260439 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.92960960 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.91521499 |
| 94 | MP0001270_distended_abdomen | 0.91259186 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.91051466 |
| 96 | MP0005257_abnormal_intraocular_pressure | 0.90385162 |
| 97 | MP0005332_abnormal_amino_acid | 0.90280087 |
| 98 | MP0002896_abnormal_bone_mineralization | 0.89252104 |
| 99 | MP0005319_abnormal_enzyme/_coenzyme | 0.88815628 |
| 100 | MP0000604_amyloidosis | 0.87789426 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.86416215 |
| 102 | MP0000858_altered_metastatic_potential | 0.86186871 |
| 103 | MP0002063_abnormal_learning/memory/cond | 0.84972976 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.84939551 |
| 105 | MP0000537_abnormal_urethra_morphology | 0.83954340 |
| 106 | MP0008874_decreased_physiological_sensi | 0.83575243 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.81729490 |
| 108 | MP0005187_abnormal_penis_morphology | 0.81178651 |
| 109 | MP0002078_abnormal_glucose_homeostasis | 0.79979560 |
| 110 | MP0004859_abnormal_synaptic_plasticity | 0.78752661 |
| 111 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78484830 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.78377158 |
| 113 | MP0000462_abnormal_digestive_system | 0.78007893 |
| 114 | MP0010234_abnormal_vibrissa_follicle | 0.77366493 |
| 115 | MP0002332_abnormal_exercise_endurance | 0.77286515 |
| 116 | MP0001915_intracranial_hemorrhage | 0.76170234 |
| 117 | MP0000609_abnormal_liver_physiology | 0.75928576 |
| 118 | MP0002653_abnormal_ependyma_morphology | 0.74521502 |
| 119 | MP0005266_abnormal_metabolism | 0.73412562 |
| 120 | MP0002971_abnormal_brown_adipose | 0.71578981 |
| 121 | MP0000534_abnormal_ureter_morphology | 0.71347657 |
| 122 | MP0003115_abnormal_respiratory_system | 0.70725374 |
| 123 | MP0003942_abnormal_urinary_system | 0.70418047 |
| 124 | MP0002128_abnormal_blood_circulation | 0.70370023 |
| 125 | MP0003329_amyloid_beta_deposits | 0.70353769 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.70240489 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.69781771 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.69497862 |
| 129 | MP0002132_abnormal_respiratory_system | 0.68522656 |
| 130 | MP0003566_abnormal_cell_adhesion | 0.68471851 |
| 131 | MP0000733_abnormal_muscle_development | 0.67065477 |
| 132 | MP0003948_abnormal_gas_homeostasis | 0.67041346 |
| 133 | MP0004947_skin_inflammation | 0.66787406 |
| 134 | MP0003075_altered_response_to | 0.66785677 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.66706946 |
| 136 | MP0002116_abnormal_craniofacial_bone | 0.65298633 |
| 137 | MP0002064_seizures | 0.63961940 |
| 138 | MP0005623_abnormal_meninges_morphology | 0.63701655 |
| 139 | MP0003632_abnormal_nervous_system | 0.62870368 |
| 140 | MP0002396_abnormal_hematopoietic_system | 0.62638877 |
| 141 | MP0003938_abnormal_ear_development | 0.61574173 |
| 142 | MP0003279_aneurysm | 0.60656074 |
| 143 | MP0002932_abnormal_joint_morphology | 0.60619446 |
| 144 | MP0003191_abnormal_cellular_cholesterol | 0.58223496 |
| 145 | MP0004272_abnormal_basement_membrane | 0.58197561 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.56562353 |
| 147 | MP0002108_abnormal_muscle_morphology | 0.55154011 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.54785628 |
| 149 | MP0002925_abnormal_cardiovascular_devel | 0.54448565 |
| 150 | MP0002089_abnormal_postnatal_growth/wei | 0.54442387 |
| 151 | MP0009672_abnormal_birth_weight | 0.53302830 |
| 152 | MP0009053_abnormal_anal_canal | 0.52807479 |
| 153 | MP0001849_ear_inflammation | 0.51974594 |
| 154 | MP0003119_abnormal_digestive_system | 0.51333589 |
| 155 | MP0000767_abnormal_smooth_muscle | 0.50419788 |
| 156 | MP0005334_abnormal_fat_pad | 0.48854333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.52399010 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.36001115 |
| 3 | Ventricular tachycardia (HP:0004756) | 5.20959767 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 4.73779745 |
| 5 | Myoglobinuria (HP:0002913) | 4.55692920 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.33834764 |
| 7 | Atrial fibrillation (HP:0005110) | 4.32101905 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.27047030 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 4.22312045 |
| 10 | Primary atrial arrhythmia (HP:0001692) | 4.08835839 |
| 11 | Bundle branch block (HP:0011710) | 3.96583926 |
| 12 | Syncope (HP:0001279) | 3.96153144 |
| 13 | Supraventricular tachycardia (HP:0004755) | 3.90085180 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.90011753 |
| 15 | Supraventricular arrhythmia (HP:0005115) | 3.85122581 |
| 16 | Muscle fiber splitting (HP:0003555) | 3.83611367 |
| 17 | Subaortic stenosis (HP:0001682) | 3.81159952 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.81159952 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.80002433 |
| 20 | Difficulty running (HP:0009046) | 3.78037725 |
| 21 | Prolonged QT interval (HP:0001657) | 3.64900700 |
| 22 | Asymmetric septal hypertrophy (HP:0001670) | 3.64231822 |
| 23 | Lipoatrophy (HP:0100578) | 3.63779708 |
| 24 | Abnormality of the calf musculature (HP:0001430) | 3.61430210 |
| 25 | Ketoacidosis (HP:0001993) | 3.57555155 |
| 26 | Ventricular fibrillation (HP:0001663) | 3.52481361 |
| 27 | Atrioventricular block (HP:0001678) | 3.49544201 |
| 28 | Ventricular arrhythmia (HP:0004308) | 3.42282216 |
| 29 | Heart block (HP:0012722) | 3.41686071 |
| 30 | Palpitations (HP:0001962) | 3.36246052 |
| 31 | Increased connective tissue (HP:0009025) | 3.24219243 |
| 32 | Ketosis (HP:0001946) | 3.19082244 |
| 33 | Abnormal atrioventricular conduction (HP:0005150) | 3.16012634 |
| 34 | Dilated cardiomyopathy (HP:0001644) | 3.15764829 |
| 35 | Hypoglycemic coma (HP:0001325) | 3.04813629 |
| 36 | Flat acetabular roof (HP:0003180) | 2.95798556 |
| 37 | Rhabdomyolysis (HP:0003201) | 2.95067381 |
| 38 | EMG: myopathic abnormalities (HP:0003458) | 2.93740258 |
| 39 | Dysmetric saccades (HP:0000641) | 2.93444244 |
| 40 | Broad face (HP:0000283) | 2.91275669 |
| 41 | Lymphangioma (HP:0100764) | 2.81446671 |
| 42 | Hemorrhage of the eye (HP:0011885) | 2.79608339 |
| 43 | Abnormal EKG (HP:0003115) | 2.67354997 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.67052939 |
| 45 | Bronchomalacia (HP:0002780) | 2.66190342 |
| 46 | Myopathic facies (HP:0002058) | 2.62061226 |
| 47 | Myotonia (HP:0002486) | 2.54632471 |
| 48 | Hyperglycinuria (HP:0003108) | 2.53170705 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.52910581 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.49347386 |
| 51 | Protrusio acetabuli (HP:0003179) | 2.47534818 |
| 52 | Stridor (HP:0010307) | 2.46570736 |
| 53 | Ankle clonus (HP:0011448) | 2.45612355 |
| 54 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.45501357 |
| 55 | Hyperammonemia (HP:0001987) | 2.42175434 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.41836555 |
| 57 | Thin bony cortex (HP:0002753) | 2.40761494 |
| 58 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.37774952 |
| 59 | Hamartoma of the eye (HP:0010568) | 2.35252722 |
| 60 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.34155981 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.30806209 |
| 62 | Dysostosis multiplex (HP:0000943) | 2.30055180 |
| 63 | Large for gestational age (HP:0001520) | 2.29484580 |
| 64 | Ulnar bowing (HP:0003031) | 2.28627954 |
| 65 | EMG: neuropathic changes (HP:0003445) | 2.28305855 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25145331 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.25145331 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.24116125 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.22976748 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.21620170 |
| 71 | Gout (HP:0001997) | 2.20850861 |
| 72 | Abnormality of the thoracic spine (HP:0100711) | 2.20024988 |
| 73 | Cervical subluxation (HP:0003308) | 2.19808936 |
| 74 | Turricephaly (HP:0000262) | 2.19056460 |
| 75 | Metaphyseal cupping (HP:0003021) | 2.17759834 |
| 76 | Asymmetry of the thorax (HP:0001555) | 2.17634309 |
| 77 | Insomnia (HP:0100785) | 2.16439096 |
| 78 | Atelectasis (HP:0100750) | 2.14962319 |
| 79 | Neuronal loss in central nervous system (HP:0002529) | 2.13807694 |
| 80 | Late onset (HP:0003584) | 2.13709349 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13403025 |
| 82 | Dicarboxylic aciduria (HP:0003215) | 2.13403025 |
| 83 | Muscle stiffness (HP:0003552) | 2.12065628 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 2.11763453 |
| 85 | Abnormality of glycine metabolism (HP:0010895) | 2.11220673 |
| 86 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.11220673 |
| 87 | Broad metatarsal (HP:0001783) | 2.10670455 |
| 88 | Shallow orbits (HP:0000586) | 2.10666580 |
| 89 | Cholelithiasis (HP:0001081) | 2.10560985 |
| 90 | Broad palm (HP:0001169) | 2.09241408 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08933417 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08933417 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08933417 |
| 94 | Limb-girdle muscle atrophy (HP:0003797) | 2.08604103 |
| 95 | Annular pancreas (HP:0001734) | 2.08307581 |
| 96 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.07807327 |
| 97 | Nuclear cataract (HP:0100018) | 2.06576527 |
| 98 | Pointed chin (HP:0000307) | 2.05193402 |
| 99 | Athetosis (HP:0002305) | 2.02770963 |
| 100 | Germ cell neoplasia (HP:0100728) | 2.01642940 |
| 101 | Polycythemia (HP:0001901) | 2.01628201 |
| 102 | Sudden cardiac death (HP:0001645) | 2.00855290 |
| 103 | Hyperacusis (HP:0010780) | 2.00382909 |
| 104 | Cerebral aneurysm (HP:0004944) | 1.99109788 |
| 105 | Type 1 muscle fiber predominance (HP:0003803) | 1.96916961 |
| 106 | Mitral regurgitation (HP:0001653) | 1.96563076 |
| 107 | Hypercortisolism (HP:0001578) | 1.96156753 |
| 108 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.95971868 |
| 109 | Ragged-red muscle fibers (HP:0003200) | 1.95823613 |
| 110 | Thin ribs (HP:0000883) | 1.95799438 |
| 111 | Disproportionate tall stature (HP:0001519) | 1.94552859 |
| 112 | Abnormality of the fingertips (HP:0001211) | 1.91904516 |
| 113 | Bowel incontinence (HP:0002607) | 1.90337580 |
| 114 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.90223711 |
| 115 | Aneurysm (HP:0002617) | 1.88368336 |
| 116 | Left ventricular hypertrophy (HP:0001712) | 1.87974129 |
| 117 | Xanthomatosis (HP:0000991) | 1.87591777 |
| 118 | Thoracic kyphosis (HP:0002942) | 1.85989136 |
| 119 | Abnormal gallbladder morphology (HP:0012437) | 1.84941758 |
| 120 | Easy fatigability (HP:0003388) | 1.84395596 |
| 121 | Visceral angiomatosis (HP:0100761) | 1.83199123 |
| 122 | Neoplasm of the heart (HP:0100544) | 1.81507032 |
| 123 | Diaphragmatic weakness (HP:0009113) | 1.80941773 |
| 124 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.80567413 |
| 125 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.80567413 |
| 126 | Abnormality of the lower motor neuron (HP:0002366) | 1.78007761 |
| 127 | Testicular atrophy (HP:0000029) | 1.77349278 |
| 128 | Hand muscle atrophy (HP:0009130) | 1.77182419 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.76961816 |
| 130 | Conjunctival hamartoma (HP:0100780) | 1.76147523 |
| 131 | Intrahepatic cholestasis (HP:0001406) | 1.74990627 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 1.74911565 |
| 133 | Cholecystitis (HP:0001082) | 1.74911565 |
| 134 | Abnormality of the aortic arch (HP:0012303) | 1.74511638 |
| 135 | Peripheral hypomyelination (HP:0007182) | 1.74317320 |
| 136 | Hypoalphalipoproteinemia (HP:0003233) | 1.73797999 |
| 137 | Bulbar palsy (HP:0001283) | 1.73315961 |
| 138 | Skin nodule (HP:0200036) | 1.73125758 |
| 139 | Vertebral compression fractures (HP:0002953) | 1.73120617 |
| 140 | Growth hormone excess (HP:0000845) | 1.71811053 |
| 141 | Distal lower limb amyotrophy (HP:0008944) | 1.70648951 |
| 142 | Abnormal large intestine physiology (HP:0012700) | 1.70640089 |
| 143 | Cupped ribs (HP:0000887) | 1.69751379 |
| 144 | Palmoplantar keratoderma (HP:0000982) | 1.69172471 |
| 145 | Supernumerary nipples (HP:0002558) | 1.68988797 |
| 146 | Precocious puberty (HP:0000826) | 1.68424151 |
| 147 | Hemangiomatosis (HP:0007461) | 1.67612517 |
| 148 | Abnormality of the periventricular white matter (HP:0002518) | 1.67573664 |
| 149 | Spinal canal stenosis (HP:0003416) | 1.66718157 |
| 150 | Elfin facies (HP:0004428) | 1.66510074 |
| 151 | Metabolic acidosis (HP:0001942) | 1.66109635 |
| 152 | Long toe (HP:0010511) | 1.65929248 |
| 153 | Neonatal death (HP:0003811) | 1.65723533 |
| 154 | Biconcave vertebral bodies (HP:0004586) | 1.65691251 |
| 155 | Lower limb asymmetry (HP:0100559) | 1.65100935 |
| 156 | Arnold-Chiari malformation (HP:0002308) | 1.64064240 |
| 157 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.64061003 |
| 158 | Hypercholesterolemia (HP:0003124) | 1.62345261 |
| 159 | Congestive heart failure (HP:0001635) | 1.61542206 |
| 160 | Achilles tendon contracture (HP:0001771) | 1.60473265 |
| 161 | Abnormal vertebral ossification (HP:0100569) | 1.60311064 |
| 162 | Neonatal onset (HP:0003623) | 1.59443056 |
| 163 | Distal upper limb amyotrophy (HP:0007149) | 1.59373000 |
| 164 | Upper limb amyotrophy (HP:0009129) | 1.59373000 |
| 165 | Polygenic inheritance (HP:0010982) | 1.58987554 |
| 166 | Bell-shaped thorax (HP:0001591) | 1.58866309 |
| 167 | Reticulocytosis (HP:0001923) | 1.57697336 |
| 168 | Rapidly progressive (HP:0003678) | 1.57529545 |
| 169 | Abnormality of the Achilles tendon (HP:0005109) | 1.56991526 |
| 170 | Mask-like facies (HP:0000298) | 1.56517604 |
| 171 | Vertebral arch anomaly (HP:0008438) | 1.56494479 |
| 172 | Deformed sella turcica (HP:0002681) | 1.56241354 |
| 173 | Abnormality of carpal bone ossification (HP:0006257) | 1.56088260 |
| 174 | Advanced eruption of teeth (HP:0006288) | 1.55482147 |
| 175 | Macroorchidism (HP:0000053) | 1.55358326 |
| 176 | Premature skin wrinkling (HP:0100678) | 1.55185370 |
| 177 | Abnormal ossification of hand bones (HP:0005921) | 1.54502953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.27141315 |
| 2 | TTN | 3.59731329 |
| 3 | PKN2 | 3.46801988 |
| 4 | PRPF4B | 2.81634010 |
| 5 | LMTK2 | 2.79069241 |
| 6 | PHKG1 | 2.78877209 |
| 7 | PHKG2 | 2.78877209 |
| 8 | MAP3K10 | 2.69369267 |
| 9 | ICK | 2.56373522 |
| 10 | SMG1 | 2.53619653 |
| 11 | SIK1 | 2.35819372 |
| 12 | DMPK | 2.34342338 |
| 13 | RIPK1 | 2.19842584 |
| 14 | BCKDK | 1.93995866 |
| 15 | ERN1 | 1.91506190 |
| 16 | EPHB2 | 1.81137776 |
| 17 | OBSCN | 1.78918522 |
| 18 | PDK4 | 1.78800343 |
| 19 | PDK3 | 1.78800343 |
| 20 | EEF2K | 1.70513802 |
| 21 | PDGFRA | 1.66144912 |
| 22 | MYLK | 1.62325339 |
| 23 | MAP3K7 | 1.61585563 |
| 24 | NEK1 | 1.61550520 |
| 25 | PTK6 | 1.56160952 |
| 26 | PRKD3 | 1.51091703 |
| 27 | EPHA2 | 1.36671090 |
| 28 | MST1R | 1.32987108 |
| 29 | CDK19 | 1.29592674 |
| 30 | TNK2 | 1.28759650 |
| 31 | NTRK3 | 1.17762910 |
| 32 | INSRR | 1.16181271 |
| 33 | WNK4 | 1.14345260 |
| 34 | FGFR4 | 1.13539564 |
| 35 | KSR1 | 1.13074473 |
| 36 | FGFR3 | 1.10799682 |
| 37 | MATK | 1.08878086 |
| 38 | TIE1 | 1.08530645 |
| 39 | CDC42BPA | 1.08164493 |
| 40 | CAMK1G | 1.07801524 |
| 41 | TYRO3 | 1.06843190 |
| 42 | EPHB1 | 1.05243445 |
| 43 | DAPK2 | 1.05170351 |
| 44 | STK38 | 1.05165681 |
| 45 | MAP3K13 | 1.05039953 |
| 46 | PAK3 | 1.02737867 |
| 47 | PRKD1 | 0.97467932 |
| 48 | PRKAA1 | 0.96471074 |
| 49 | MAPK15 | 0.95722489 |
| 50 | RIPK4 | 0.89394959 |
| 51 | CAMK1D | 0.86763436 |
| 52 | MTOR | 0.86220855 |
| 53 | MAP3K11 | 0.85434216 |
| 54 | KSR2 | 0.83519588 |
| 55 | MAP4K1 | 0.83015797 |
| 56 | MAP3K6 | 0.82019190 |
| 57 | PRKAA2 | 0.80843509 |
| 58 | FLT3 | 0.79820898 |
| 59 | CAMK4 | 0.79577925 |
| 60 | PAK6 | 0.78505413 |
| 61 | MAP2K4 | 0.78462156 |
| 62 | CDK12 | 0.78020106 |
| 63 | FGFR2 | 0.77472868 |
| 64 | TAOK1 | 0.76241486 |
| 65 | RET | 0.75836944 |
| 66 | DYRK1B | 0.74433719 |
| 67 | MAPK12 | 0.69753572 |
| 68 | TESK1 | 0.69487692 |
| 69 | DDR2 | 0.68776472 |
| 70 | ERBB2 | 0.68095958 |
| 71 | PINK1 | 0.68036152 |
| 72 | ROCK1 | 0.66170065 |
| 73 | MAP2K3 | 0.65885021 |
| 74 | HIPK2 | 0.65781154 |
| 75 | NTRK2 | 0.64225882 |
| 76 | PRKCH | 0.63036519 |
| 77 | STK11 | 0.62764940 |
| 78 | TAOK2 | 0.62685152 |
| 79 | TGFBR2 | 0.62176698 |
| 80 | WNK1 | 0.61769941 |
| 81 | CAMKK1 | 0.61575026 |
| 82 | ILK | 0.61336706 |
| 83 | MAPKAPK3 | 0.60685948 |
| 84 | NME1 | 0.60291755 |
| 85 | SGK3 | 0.60088930 |
| 86 | NTRK1 | 0.59913411 |
| 87 | MAP2K6 | 0.59865336 |
| 88 | EPHA4 | 0.59807873 |
| 89 | STK4 | 0.58916078 |
| 90 | PDK2 | 0.58791555 |
| 91 | MARK2 | 0.58420148 |
| 92 | PTK2B | 0.57777936 |
| 93 | SIK2 | 0.57659129 |
| 94 | LATS2 | 0.57267581 |
| 95 | DAPK3 | 0.57106708 |
| 96 | LRRK2 | 0.56856976 |
| 97 | CDK15 | 0.56794191 |
| 98 | CDK11A | 0.55960739 |
| 99 | MAPK10 | 0.54377360 |
| 100 | IRAK3 | 0.53957677 |
| 101 | MAPK7 | 0.53586774 |
| 102 | ZAP70 | 0.53021571 |
| 103 | STK24 | 0.52933465 |
| 104 | MAP3K1 | 0.52502542 |
| 105 | MAP2K2 | 0.52489126 |
| 106 | TYK2 | 0.52015217 |
| 107 | NEK6 | 0.51936420 |
| 108 | PDPK1 | 0.51513684 |
| 109 | MAPK11 | 0.51431693 |
| 110 | UHMK1 | 0.50417471 |
| 111 | MAP3K3 | 0.50053210 |
| 112 | MET | 0.48958074 |
| 113 | RPS6KA2 | 0.48540554 |
| 114 | CDK18 | 0.48492169 |
| 115 | PDGFRB | 0.47064552 |
| 116 | PAK4 | 0.46460900 |
| 117 | RPS6KC1 | 0.46336010 |
| 118 | RPS6KL1 | 0.46336010 |
| 119 | PRKG2 | 0.45509215 |
| 120 | RPS6KA1 | 0.45469162 |
| 121 | PRKD2 | 0.45139552 |
| 122 | PRKACG | 0.44249870 |
| 123 | PRKCI | 0.44079544 |
| 124 | PTK2 | 0.43610212 |
| 125 | JAK2 | 0.43451574 |
| 126 | BMX | 0.43128203 |
| 127 | SGK494 | 0.42922395 |
| 128 | SGK223 | 0.42922395 |
| 129 | MAPK8 | 0.42716229 |
| 130 | GRK6 | 0.42464866 |
| 131 | CAMK1 | 0.42134141 |
| 132 | TBK1 | 0.41911266 |
| 133 | AKT2 | 0.41771556 |
| 134 | CDK5 | 0.40658826 |
| 135 | PDK1 | 0.40069393 |
| 136 | ALK | 0.39168153 |
| 137 | ROCK2 | 0.38501227 |
| 138 | ARAF | 0.38417119 |
| 139 | PIK3CA | 0.37559325 |
| 140 | RPS6KA6 | 0.36506494 |
| 141 | KDR | 0.35791783 |
| 142 | CAMK2D | 0.35462407 |
| 143 | SIK3 | 0.34928500 |
| 144 | RPS6KA3 | 0.34129420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.62548741 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40913015 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.38263660 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.00335732 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.85675506 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51102808 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.37171975 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24353721 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12761962 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.04516610 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99751726 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93564108 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92199561 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.90813018 |
| 15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89749274 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.86428872 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.80335164 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.68275505 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.63316889 |
| 20 | Lysine degradation_Homo sapiens_hsa00310 | 1.62974102 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.56168104 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52447287 |
| 23 | Bile secretion_Homo sapiens_hsa04976 | 1.48505790 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.47469460 |
| 25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46440048 |
| 26 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.40821401 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.38960936 |
| 28 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37986843 |
| 29 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.35745684 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.34736449 |
| 31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.33396281 |
| 32 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.32849881 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.30369149 |
| 34 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.28614965 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28434689 |
| 36 | Insulin resistance_Homo sapiens_hsa04931 | 1.28142490 |
| 37 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.28132247 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24811725 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.23153488 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20299869 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18250072 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.16213346 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.14194685 |
| 44 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.14171341 |
| 45 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.13751330 |
| 46 | Long-term potentiation_Homo sapiens_hsa04720 | 1.13712724 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.13446988 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.10262205 |
| 49 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06961826 |
| 50 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05552795 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05416830 |
| 52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05105810 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00793536 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99069353 |
| 55 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98593710 |
| 56 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98118741 |
| 57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.94853874 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.92170683 |
| 59 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.91858727 |
| 60 | Histidine metabolism_Homo sapiens_hsa00340 | 0.90152636 |
| 61 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89638306 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.88888968 |
| 63 | Bladder cancer_Homo sapiens_hsa05219 | 0.87711422 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 0.86114974 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85116884 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84315898 |
| 67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.83077231 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.82923863 |
| 69 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82190910 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.80938650 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80899861 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.80438244 |
| 73 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80128854 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.78893286 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78585571 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.78308298 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77910020 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77721518 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.77229505 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.76411580 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75781876 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.74280458 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72804809 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72419292 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70558045 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70526394 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.69815455 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68876981 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68876654 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.67219471 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66195296 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65699718 |
| 93 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64633623 |
| 94 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64150247 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.63661599 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63080264 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62974424 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.61595773 |
| 99 | Prostate cancer_Homo sapiens_hsa05215 | 0.61456205 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60117635 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59216970 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.58878923 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58153191 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57682617 |
| 105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56292916 |
| 106 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56204723 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56014485 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55454876 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54900683 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54240109 |
| 111 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.54197715 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53986375 |
| 113 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52900764 |
| 114 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52332263 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.51564890 |
| 116 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.50611135 |
| 117 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50357290 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.50286650 |
| 119 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49896885 |
| 120 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.48893868 |
| 121 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48154163 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.47502339 |
| 123 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46766847 |
| 124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46572603 |
| 125 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.44808509 |
| 126 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44482843 |
| 127 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43557237 |
| 128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42485910 |
| 129 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42304631 |
| 130 | Adherens junction_Homo sapiens_hsa04520 | 0.39787005 |
| 131 | Salivary secretion_Homo sapiens_hsa04970 | 0.38893356 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38581275 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.38078919 |
| 134 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38044621 |
| 135 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36746466 |
| 136 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35619814 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.34790410 |
| 138 | Melanogenesis_Homo sapiens_hsa04916 | 0.34470691 |
| 139 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33292526 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33003431 |
| 141 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31503632 |
| 142 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31338740 |
| 143 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.29006276 |
| 144 | Gap junction_Homo sapiens_hsa04540 | 0.28768256 |
| 145 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28090976 |
| 146 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.27367855 |

